Bank of America’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-467,700
Closed -$357M 7930
2025
Q3
$357M Sell
467,700
-52,800
-10% -$39.3M 0.02% 561
2025
Q2
$406M Sell
520,500
-500
-0.1% -$389K 0.03% 501
2025
Q1
$430M Buy
521,000
+167,700
+47% +$140M 0.03% 451
2024
Q4
$273M Buy
353,300
+62,400
+21% +$51.7M 0.02% 577
2024
Q3
$258M Buy
290,900
+110,700
+61% +$99.5M 0.02% 624
2024
Q2
$163M Sell
180,200
-36,500
-17% -$29.2M 0.01% 769
2024
Q1
$169M Sell
216,700
-132,600
-38% -$94.4M 0.02% 766
2023
Q4
$204M Sell
349,300
-50,200
-13% -$29.3M 0.02% 610
2023
Q3
$215M Buy
399,500
+169,800
+74% +$87.5M 0.02% 558
2023
Q2
$108M Sell
229,700
-184,800
-45% -$77.5M 0.01% 861
2023
Q1
$142M Buy
414,500
+66,100
+19% +$22.3M 0.01% 766
2022
Q4
$127M Buy
348,400
+222,900
+178% +$79M 0.01% 768
2022
Q3
$40.6M Sell
125,500
-292,500
-70% -$92.7M ﹤0.01% 1408
2022
Q2
$136M Buy
418,000
+125,200
+43% +$37.6M 0.02% 752
2022
Q1
$83.8M Buy
292,800
+146,200
+100% +$37.6M 0.01% 1048
2021
Q4
$40.5M Buy
146,600
+52,000
+55% +$13.2M ﹤0.01% 1574
2021
Q3
$21.9M Sell
94,600
-108,700
-53% -$26.8M ﹤0.01% 2100
2021
Q2
$46.7M Buy
203,300
+121,800
+149% +$24.5M ﹤0.01% 1409
2021
Q1
$15.2M Buy
81,500
+28,400
+53% +$5.56M ﹤0.01% 2295
2020
Q4
$8.96M Buy
53,100
+21,500
+68% +$3.21M ﹤0.01% 2581
2020
Q3
$4.68M Sell
31,600
-12,600
-29% -$1.95M ﹤0.01% 2975
2020
Q2
$7.26M Sell
44,200
-24,600
-36% -$3.78M ﹤0.01% 2511
2020
Q1
$9.54M Buy
68,800
+4,800
+8% +$660K ﹤0.01% 2099
2019
Q4
$8.41M Buy
64,000
+1,300
+2% +$151K ﹤0.01% 2728
2019
Q3
$7.01M Sell
62,700
-10,900
-15% -$1.21M ﹤0.01% 2865
2019
Q2
$8.15M Sell
73,600
-10,800
-13% -$1.27M ﹤0.01% 2762
2019
Q1
$11M Buy
84,400
+19,100
+29% +$2.32M ﹤0.01% 2391
2018
Q4
$7.56M Sell
65,300
-204,300
-76% -$22.8M ﹤0.01% 2568
2018
Q3
$28.9M Buy
269,600
+204,500
+314% +$20.4M ﹤0.01% 1521
2018
Q2
$5.55M Sell
65,100
-54,900
-46% -$4.51M ﹤0.01% 3050
2018
Q1
$9.28M Sell
120,000
-295,800
-71% -$23.8M ﹤0.01% 2481
2017
Q4
$35.1M Sell
415,800
-4,900
-1% -$417K 0.01% 1365
2017
Q3
$36M Sell
420,700
-60,500
-13% -$4.96M 0.01% 1407
2017
Q2
$39.6M Buy
481,200
+11,300
+2% +$922K 0.01% 1189
2017
Q1
$39.5M Sell
469,900
-41,400
-8% -$3.32M 0.01% 1194
2016
Q4
$37.6M Sell
511,300
-244,900
-32% -$18.2M 0.01% 1190
2016
Q3
$60.7M Buy
756,200
+184,600
+32% +$14.8M 0.01% 866
2016
Q2
$45M Buy
571,600
+263,700
+86% +$19.9M 0.01% 1048
2016
Q1
$22.2M Sell
307,900
-173,600
-36% -$13.1M 0.01% 1485
2015
Q4
$40.6M Buy
481,500
+87,600
+22% +$7.27M 0.01% 1128
2015
Q3
$33M Buy
393,900
+33,100
+9% +$2.79M 0.01% 1249
2015
Q2
$30.1M Buy
360,800
+160,500
+80% +$12.2M 0.01% 1124
2015
Q1
$14.6M Buy
200,300
+112,200
+127% +$7.99M ﹤0.01% 1592
2014
Q4
$6.08M Buy
88,100
+4,900
+6% +$331K ﹤0.01% 2378
2014
Q3
$5.39M Sell
83,200
-282,700
-77% -$17.9M ﹤0.01% 2512
2014
Q2
$22.7M Sell
365,900
-158,800
-30% -$9.47M 0.01% 1313
2014
Q1
$30.9M Buy
524,700
+32,100
+7% +$1.79M 0.01% 998
2013
Q4
$25.1M Sell
492,600
-106,600
-18% -$5.34M 0.01% 1168
2013
Q3
$30.2M Buy
599,200
+8,200
+1% +$429K 0.01% 982
2013
Q2
$29M Buy
+591,000
New +$32.2M 0.01% 975

Other funds holding LLY

Bank of America's LLY Position: Q1 2026 in Review

Bank of America increased its Eli Lilly (LLY) stake by 0.18% in Q1 2026, buying an estimated $20.5M and bringing the position to 11,125,832 shares worth $10.2B. The position accounts for 0.75% of the portfolio, ranked #22.

Bank of America first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.9B in Q4 2025. 4,366 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Bank of America held 11,125,832 shares of Eli Lilly worth $10.2B as of Q1 2026.
  • Bank of America bought 20,246 Eli Lilly shares in Q1 2026, an estimated $20.5M.
  • Eli Lilly made up 0.75% of Bank of America's portfolio in Q1 2026, its #22 holding.
  • Bank of America first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Eli Lilly position peaked at $11.9B in Q4 2025.
  • 4,366 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.